Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Timolol in pediatric glaucoma
NCT01652664Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2012
- Primary completion
- Mar 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 3 trial of travoprost in Glaucoma, ocular hypertension, sponsored by Alcon Inc.. Started Sep 2012; status: completed.
02
Drugs
travoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01652664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652664.